SmokingI2QNCT02596061
In It To Quit: Commitment Contracts for Smoking Cessation
A study testing Deposit Contract and Incentives in people with Smoking, run by Community Health Center, Inc. at 1 site in United States.
Trial summary
This study aims to examine whether a combination of positive and negative commitment devices is effective at inducing long-term smoking cessation in smokers from a low-to-moderate income background. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Smoking
- What is being tested?
- Deposit Contract and Incentives
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 311 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2015to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Must be Community Health Center, Inc. medical patients
- Must have had a clinic visit within the previous 2 years
- Daily smoker, with smoking status verified by self-reports in clinic medical records
- Age 18 or over; 19 or over if pregnant
- Has regular access to internet on computer or smartphone
- Not currently enrolled in R2Q and, if formerly enrolled in R2Q, not assigned to the intervention group.
- Speaks English and/or Spanish
Who cannot join
- Illiterate patients that do not have someone who can assist them during the study
Trial locations and contacts
1 site in 1 country.
United States1 site
Community Health Center, Inc.
Middletown, Connecticut, 06457
About this study
This study aims to examine whether a combination of positive and negative commitment devices is effective at inducing long-term smoking cessation in smokers from a low-to-moderate income background. Investigators will randomly assign patients of a multi-site clinic in Connecticut to receive one or both of a succession of two commitment contracts. First, a two-month reward contract will pay participants for (a) engaging in clinic and web-based activities that support smoking cessation and (b) quitting smoking, as measured at period end. Second, a four-month deposit contract will invite participants to commit funds which they forfeit unless they abstain from smoking over the entire period. A random subset of participants will also have the option to pre-commit to the deposit contract at study enrollment. Reward payout and deposit recovery will be conditional on biochemical verification of self-reported abstinence. Investigators will conduct follow-up biochemical verification at 12 months to observe whether abstinence persists after removal of incentives. The primary outcome of interest will be continuous abstinence from smoking between months 2 and 12, i.e. biochemically verified abstinence at all three measurements. A short baseline and endline survey will also be administered to measure characteristics and outcomes related to smoking behavior.
Read the detailed description
When patients arrive at the enrollment meeting, research staff will walk them through the informed consent form to explain and answer questions about the study. Patients who sign the consent form enroll in the study. Those who choose not to enroll are thanked for their time and encouraged to use CHCI smoking cessation services, regardless.
After providing written consent to participate in the study, patients will complete a short (15 minute) baseline survey assessing their smoking habits. Patients will complete the survey on their own or with the assistance of a research staff member. See Appendix B for the survey instrument.
Immediately following the survey, randomization will occur, corresponding to the two phases of the intervention. Patients will be blinded to randomization. Randomization is done offsite using Stata. The research staff will enter basic, unidentifiable information about the patient into a web interface designed specifically for the purpose of this study and receive a treatment assignment for that participant. In this way, the enrollment staff does not deal directly with the randomization process. Patients are assigned to one of four study arms: Control, Treatment 1: Rewards Only, Treatment 2: Rewards w/ pre-commitment for deposit contract, Treatment 3: Rewards w/ commitment for deposit contract at 2 months.
Soon after enrollment, patients will receive an automated call verifying participation.
Phase I runs from study enrollment through the first biochemical verification of abstinence from smoking ("biochemical test"), at 2 months. Study participants assigned to the treatment group, but not the control, will receive rewards in the form of gift cards for engaging in the smoking cessation activities ("process") and for a negative result on the biochemical test ("outcome").
Process:
Five process activities will be rewarded for treatment group members:
- One-time sign up reward for stickK.com
- submitting a weekly self-report of smoking abstinence on stickK
- writing a stickK journal entry
- enlisting family and friends to register as stickK "Supporters" to track progress and provide positive reinforcement,
- utilizing CHCI group or individual counseling services provided by a nurse or behavioral health provider
When possible, initial appointments with counseling services will be offered on the same day as the enrollment visit using CHCI's "warm handoff" behavioral health appointments. Participants will be encouraged to log their completion of these visits on stickK, and research staff will verify on stickK that the patient attended and completed a valid smoking cessation clinic visit.
For each completed and verified process activity, treatment group participants accrue points on stickK that can be redeemed for a gift card to a retail store at Phase I end, conditional on biochemical verification of smoking cessation. If the participant fails to demonstrate abstinence, s/he forfeits all accrued process points.
Members of the control group will not receive information about stickK or a stickK account associated with the study, though they may sign up for the online service independently. The control group will receive information about and have access to CHCI's full menu of smoking cessation services.
Biochemical verification:
The biochemical tests will be conducted two months after study enrollment. Research staff will contact patients via phone and/or email to schedule visits to complete these tests. Investigators will ask all control group members to take the test and compensate them for doing so, regardless of test result ("measurement incentive"). Only treatment group members who self-report not smoking during the last week, or from whom investigators were unable to procure a self-report, will be asked to take the test. This group will not receive a measurement incentive.
All patients will first complete a CO breathalyzer test. Those that test positive will have no further testing. Those testing negative will have a urine verification test at the in-house Quest Diagnostics. Test results will be sent to the EHR.
Process and outcome changes are rewarded according to the following schedule:
Phase I end: redemption of rewards or adoption of deposit contract. The majority of participants will receive confirmation of their smoking status at the clinic within a few minutes of taking the test. Research staff will verify the confirmatory test result on stickK and assist participants as they adopt the deposit contract or redeem their rewards. The deposit contract is a commitment device that allows users to voluntarily "deposit" rewards that they can only recover if they succeed in achieving a predetermined goal, which, in this case, is maintaining smoking abstinence over the four-month Phase II period. In other words, participants who elect to use the deposit contract risk losing some or all of the rewards they accrued during the "rewards phase" if they fail to test negative for smoking at Phase II end.
Protocol by biochemical test result, randomized assignment, and take-up decision:
- Test positive for smoking -> lose accrued process rewards; not eligible for deposit contract
- Test negative for smoking, and
- No deposit contract -> redeem process and outcome rewards
- Deposit contract-pre-commitment and pre-committed -> confirm, adjust, or opt-out of commitment
- Deposit contract-pre-commitment and did not pre-commit -> receive deposit contract offer one final time
- Deposit contract- No pre-commitment -> receive deposit contract offer for the first and final time
Those who are eligible for but decline the deposit contract redeem 100% of their rewards. The intervention ends after Phase I for these individuals.
Those who adopt the deposit contract redeem the percentage of their rewards that they did not invest in the deposit contract. The rest is automatically rolled into the deposit contract, and the contract period, i.e. Phase II of the intervention, begins immediately.
Phase II: Deposit contract, months 3 through 6. Phase II lasts 4 months, from month 3 through 6. The majority of study participants won't hold a deposit contract and thus won't experience an active intervention during this time. Participants who do hold a deposit contract will be free to engage with stickK as they like (e.g. write journal entries, share progress on social media), but will not receive rewards for doing so.
At 6 months, investigators will ask all study participants to take the second confirmatory test. Participants without a deposit contract will receive a measurement incentive to take the test but no performance incentives contingent on the test result. For deposit contract holders, recovery of the deposit will be contingent on testing negative for smoking.
Measurement of long-term smoking abstinence:
At month 12, all study participants will be asked to visit the clinic for a final confirmatory test, and all will receive a measurement incentive. No incentives are contingent on smoking status.
An endline survey will be administered at this time. The endline survey will be self-administered by participants either via email, mailing, or in person depending on the availability of participants.
- Conditions
- Smoking
- Being tested
- Deposit Contract, Incentives
- Medical subject headings
- Smoking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Deposit ContractBehavioural
Contracts prompt patients to put money they have earned at stake on a commitment to remain smoke-free for a longer period of time.
IncentivesOther
Patients receive incentives for completing smoking cessation activities.
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | These participants are made aware of all smoking cessation services offered by the clinic, for example group counseling or individual counseling, but are not offered any rewards for participating in these activities. |
| Intervention-Rewards Only | Experimental | Patients have access to a website where they can self-report smoking status, add virtual supporters, and submit journal entries. Patients receive incentives for completing these activities and for utilizing counseling services at the clinic. At the 2 mo. mark, these participants come to the clinic for a biochemical verification of their smoking status. Their rewards are contingent on successfully passing this verification test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. Receives: Other: Incentives |
| Intervention-Pre-Commitment | Experimental | Patients have access to a website where they can self-report smoking status, add supporters, and submit journal entries. Patients receive incentives for these activities and for using clinic counseling services. At enrollment, patients are offered the chance to set aside some of their future rewards for a deposit contract that lasts for 4 mos. and starts 2 mos. after the rewards contract. If, at the end of 6 mos., the patients pass the second verification test, their rewards are returned to them. At the 2 mo. mark, patients come to the clinic for a biochemical verification of their smoking status. Rewards are contingent on passing this test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. Receives: Behavioral: Deposit Contract; Other: Incentives |
| Intervention-Commitment | Experimental | Patients have access to a website where they can self-report smoking status, add virtual supporters, and submit journal entries. Patients receive incentives for these activities and for using clinic counseling services. After 2 mos., this group is offered the chance to set aside some of their rewards towards a deposit contract that lasts for 4 months. If, after the 4 mos., the patients pass the second cessation verification test, their rewards are returned to them. At the 2 mo. mark, these patients come to the clinic for a biochemical verification of their smoking status. Rewards are contingent on passing this test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. Receives: Behavioral: Deposit Contract; Other: Incentives |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in smoking cessation rates
The primary outcome of interest will be continuous abstinence from smoking between months 2 and 12, i.e. biochemically verified abstinence at all three measurements (2, 6 and 12 months)
Measured: 2, 6, and 12 months post-enrollment
Secondary outcomes (2)
Process Participation Rates
One secondary outcome will be rates of participation in the various activities promoted for aiding in smoking cessation i.e. counseling, journaling, medication usage.
Measured: 2 months post-enrollment
Uptake rates of commitment contracts
The final secondary outcome will be the rates of acceptance of commitment contracts by patients offered these devices.
Measured: 2 months post-enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2015 (estimated)
- Study startNov 2015
- Primary completionNov 2017
- Study completionDec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SmokingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 311 participants (actual)
Sponsor and investigators
- Lead sponsor
- Community Health Center, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Innovations for Poverty Action, Yale University
- Responsible party
- Sponsor
- Investigators
- Daren Anderson, MD, Principal investigator, Vice President/Director of Weitzman Institute/Chief Quality Officer
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02596061
- Sponsor's protocol ID
- 1071
- Acronym
- I2Q
- Status last verified
- Jan 2018
- First submitted
- 23 Oct 2015
- Last updated
- 26 Jan 2018
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- In It To Quit: Commitment Contracts for Smoking Cessation
- ClinicalTrials.gov ID
- NCT02596061
- Acronym / sponsor ID
- I2Q / 1071
- Conditions
- Smoking
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 311 participants (actual)
- Lead sponsor
- Community Health Center, Inc.Industry (pharma, biotech, devices)
- Collaborators
- Innovations for Poverty Action, Yale University
- Study start
- Nov 2015
- Primary completion
- Nov 2017 (actual)
- Study completion
- Dec 2017 (actual)
- First posted
- 4 Nov 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to examine whether a combination of positive and negative commitment devices is effective at inducing long-term smoking cessation in smokers from a low-to-moderate income background. Investigators will randomly assign patients of a multi-site clinic in Connecticut to receive one or both of a succession of two commitment contracts. First, a two-month reward contract will pay participants for (a) engaging in clinic and web-based activities that support smoking cessation and (b) quitting smoking, as measured at period end. Second, a four-month deposit contract will invite participants to commit funds which they forfeit unless they abstain from smoking over the entire period. A random subset of participants will also have the option to pre-commit to the deposit contract at study enrollment. Reward payout and deposit recovery will be conditional on biochemical verification of self-reported abstinence. Investigators will conduct follow-up biochemical verification at 12 months to observe whether abstinence persists after removal of incentives. The primary outcome of interest will be continuous abstinence from smoking between months 2 and 12, i.e. biochemically verified abstinence at all three measurements. A short baseline and endline survey will also be administered to measure characteristics and outcomes related to smoking behavior.
Detailed description
When patients arrive at the enrollment meeting, research staff will walk them through the informed consent form to explain and answer questions about the study. Patients who sign the consent form enroll in the study. Those who choose not to enroll are thanked for their time and encouraged to use CHCI smoking cessation services, regardless.
After providing written consent to participate in the study, patients will complete a short (15 minute) baseline survey assessing their smoking habits. Patients will complete the survey on their own or with the assistance of a research staff member. See Appendix B for the survey instrument.
Immediately following the survey, randomization will occur, corresponding to the two phases of the intervention. Patients will be blinded to randomization. Randomization is done offsite using Stata. The research staff will enter basic, unidentifiable information about the patient into a web interface designed specifically for the purpose of this study and receive a treatment assignment for that participant. In this way, the enrollment staff does not deal directly with the randomization process. Patients are assigned to one of four study arms: Control, Treatment 1: Rewards Only, Treatment 2: Rewards w/ pre-commitment for deposit contract, Treatment 3: Rewards w/ commitment for deposit contract at 2 months.
Soon after enrollment, patients will receive an automated call verifying participation.
Phase I runs from study enrollment through the first biochemical verification of abstinence from smoking ("biochemical test"), at 2 months. Study participants assigned to the treatment group, but not the control, will receive rewards in the form of gift cards for engaging in the smoking cessation activities ("process") and for a negative result on the biochemical test ("outcome").
Process:
Five process activities will be rewarded for treatment group members:
- One-time sign up reward for stickK.com
- submitting a weekly self-report of smoking abstinence on stickK
- writing a stickK journal entry
- enlisting family and friends to register as stickK "Supporters" to track progress and provide positive reinforcement,
- utilizing CHCI group or individual counseling services provided by a nurse or behavioral health provider
When possible, initial appointments with counseling services will be offered on the same day as the enrollment visit using CHCI's "warm handoff" behavioral health appointments. Participants will be encouraged to log their completion of these visits on stickK, and research staff will verify on stickK that the patient attended and completed a valid smoking cessation clinic visit.
For each completed and verified process activity, treatment group participants accrue points on stickK that can be redeemed for a gift card to a retail store at Phase I end, conditional on biochemical verification of smoking cessation. If the participant fails to demonstrate abstinence, s/he forfeits all accrued process points.
Members of the control group will not receive information about stickK or a stickK account associated with the study, though they may sign up for the online service independently. The control group will receive information about and have access to CHCI's full menu of smoking cessation services.
Biochemical verification:
The biochemical tests will be conducted two months after study enrollment. Research staff will contact patients via phone and/or email to schedule visits to complete these tests. Investigators will ask all control group members to take the test and compensate them for doing so, regardless of test result ("measurement incentive"). Only treatment group members who self-report not smoking during the last week, or from whom investigators were unable to procure a self-report, will be asked to take the test. This group will not receive a measurement incentive.
All patients will first complete a CO breathalyzer test. Those that test positive will have no further testing. Those testing negative will have a urine verification test at the in-house Quest Diagnostics. Test results will be sent to the EHR.
Process and outcome changes are rewarded according to the following schedule:
Phase I end: redemption of rewards or adoption of deposit contract. The majority of participants will receive confirmation of their smoking status at the clinic within a few minutes of taking the test. Research staff will verify the confirmatory test result on stickK and assist participants as they adopt the deposit contract or redeem their rewards. The deposit contract is a commitment device that allows users to voluntarily "deposit" rewards that they can only recover if they succeed in achieving a predetermined goal, which, in this case, is maintaining smoking abstinence over the four-month Phase II period. In other words, participants who elect to use the deposit contract risk losing some or all of the rewards they accrued during the "rewards phase" if they fail to test negative for smoking at Phase II end.
Protocol by biochemical test result, randomized assignment, and take-up decision:
- Test positive for smoking -> lose accrued process rewards; not eligible for deposit contract
- Test negative for smoking, and
- No deposit contract -> redeem process and outcome rewards
- Deposit contract-pre-commitment and pre-committed -> confirm, adjust, or opt-out of commitment
- Deposit contract-pre-commitment and did not pre-commit -> receive deposit contract offer one final time
- Deposit contract- No pre-commitment -> receive deposit contract offer for the first and final time
Those who are eligible for but decline the deposit contract redeem 100% of their rewards. The intervention ends after Phase I for these individuals.
Those who adopt the deposit contract redeem the percentage of their rewards that they did not invest in the deposit contract. The rest is automatically rolled into the deposit contract, and the contract period, i.e. Phase II of the intervention, begins immediately.
Phase II: Deposit contract, months 3 through 6. Phase II lasts 4 months, from month 3 through 6. The majority of study participants won't hold a deposit contract and thus won't experience an active intervention during this time. Participants who do hold a deposit contract will be free to engage with stickK as they like (e.g. write journal entries, share progress on social media), but will not receive rewards for doing so.
At 6 months, investigators will ask all study participants to take the second confirmatory test. Participants without a deposit contract will receive a measurement incentive to take the test but no performance incentives contingent on the test result. For deposit contract holders, recovery of the deposit will be contingent on testing negative for smoking.
Measurement of long-term smoking abstinence:
At month 12, all study participants will be asked to visit the clinic for a final confirmatory test, and all will receive a measurement incentive. No incentives are contingent on smoking status.
An endline survey will be administered at this time. The endline survey will be self-administered by participants either via email, mailing, or in person depending on the availability of participants.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –These participants are made aware of all smoking cessation services offered by the clinic, for example group counseling or individual counseling, but are not offered any rewards for participating in these activities. |
| Intervention-Rewards Only | Experimental | Other: IncentivesPatients have access to a website where they can self-report smoking status, add virtual supporters, and submit journal entries. Patients receive incentives for completing these activities and for utilizing counseling services at the clinic. At the 2 mo. mark, these participants come to the clinic for a biochemical verification of their smoking status. Their rewards are contingent on successfully passing this verification test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. |
| Intervention-Pre-Commitment | Experimental | Behavioral: Deposit Contract, Other: IncentivesPatients have access to a website where they can self-report smoking status, add supporters, and submit journal entries. Patients receive incentives for these activities and for using clinic counseling services. At enrollment, patients are offered the chance to set aside some of their future rewards for a deposit contract that lasts for 4 mos. and starts 2 mos. after the rewards contract. If, at the end of 6 mos., the patients pass the second verification test, their rewards are returned to them. At the 2 mo. mark, patients come to the clinic for a biochemical verification of their smoking status. Rewards are contingent on passing this test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. |
| Intervention-Commitment | Experimental | Behavioral: Deposit Contract, Other: IncentivesPatients have access to a website where they can self-report smoking status, add virtual supporters, and submit journal entries. Patients receive incentives for these activities and for using clinic counseling services. After 2 mos., this group is offered the chance to set aside some of their rewards towards a deposit contract that lasts for 4 months. If, after the 4 mos., the patients pass the second cessation verification test, their rewards are returned to them. At the 2 mo. mark, these patients come to the clinic for a biochemical verification of their smoking status. Rewards are contingent on passing this test. They are also asked to return to the clinic 6 and 12 mos. after enrollment to complete the smoking tests and are compensated for these 2 visits. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Must be Community Health Center, Inc. medical patients
- Must have had a clinic visit within the previous 2 years
- Daily smoker, with smoking status verified by self-reports in clinic medical records
- Age 18 or over; 19 or over if pregnant
- Has regular access to internet on computer or smartphone
Key exclusion criteria (1 listed)
- Illiterate patients that do not have someone who can assist them during the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Deposit ContractContracts prompt patients to put money they have earned at stake on a commitment to remain smoke-free for a longer period of time. | Behavioural | Intervention-Commitment, Intervention-Pre-Commitment |
| IncentivesPatients receive incentives for completing smoking cessation activities. | Other | Intervention-Commitment, Intervention-Pre-Commitment, Intervention-Rewards Only |
Primary outcome
Change in smoking cessation rates
Time frame: 2, 6, and 12 months post-enrollment
The primary outcome of interest will be continuous abstinence from smoking between months 2 and 12, i.e. biochemically verified abstinence at all three measurements (2, 6 and 12 months)
2 secondary outcomes
Process Participation Rates
Time frame: 2 months post-enrollment
Uptake rates of commitment contracts
Time frame: 2 months post-enrollment
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2018.
Related trials for Smoking
Active, not recruiting
An Interactive Smartphone Application to Motivate Smokers to Quit
Smoking Cessation, Smoking Behaviors
Not yet recruiting
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Not yet recruiting
Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students; A Randomized Controlled Trial.
Conversational Agent, Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Active, not recruitingPhase 3
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Tobacco Dependence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daren Anderson, MD principal investigator
Vice President/Director of Weitzman Institute/Chief Quality Officer
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Deposit Contract and Incentives in people with Smoking, run by Community Health Center, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in smoking cessation rates (time frame: 2, 6, and 12 months post-enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2018.